LegoChem Biosciences
Manufacturing · 11-50 Employees
View Company Info for Free
Overview
Website
www.ligachembio.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
2
1
1
1
1
1
About LegoChem Biosciences
LigaChem Biosciences is a biotech company dedicated to innovative drug development for over 30 years, leveraging advanced technologies and open innovation to pave new paths in global drug development. The company focuses on addressing unmet medical needs through the development of innovative therapeutics, including next-generation antibody-drug conjugates (ADCs) and small molecule therapies. LigaChem collaborates with global partners for joint research, development, and licensing to accelerate the creation of new drugs. Their commitment to ESG management reflects a dedication to sustainable leadership within the community.Explore more
Popular SearchesLegoChem BiosciencesSIC Code 28,283NAICS Code 32,325Show moreLegoChem Biosciences Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is LegoChem Biosciences your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if LegoChem Biosciences had a recent Job posting/layoffs
LegoChem Biosciences, which may be a good buyer, showed buying intent in Masked Content Topic
Check if LegoChem Biosciences has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at LegoChem Biosciences
Check out if LegoChem Biosciences is spiking on competitors!
Funding: Get notified immidiatlly once LegoChem Biosciences has new funding data
Product Launch: Get notified when LegoChem Biosciences launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on LegoChem Biosciences recently announced quarterly report
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Company Profile Activity
Activity Insights
LegoChem Biosciences is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
LegoChem Biosciences is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about LegoChem Biosciences.
Most Recent Scoops
Partnership
Partnership, Product Development, Product Management, Intellectual Property
Product Launch
Product Development, Research & Development, Intellectual Property
Promotion
Executive Move
Chul-Woong Chung has been promoted from Vice President Head of Research & Development to the role of Chief Technology Officer.
Partnership
LegoChem Biosciences News & Media
Samsung Biologics partners with LegoChem Biosciences for ADC development and manufacturing
- Samsung Biologics to develop and manufacture antibody for ADC candidate - Latest deal comes as Samsung Biologics is on track to complete construction of an ADC facility this year INCHEON, South Korea, Feb. 7, 2024 /PRNewswire/ -- Samsung Biologics (KRX: 207940.KS), a global contract...Orion Invests $415M in Korean Biotech LegoChem, Secures Majority Stake | BioSpace
Once completed, antibody-drug conjugate developer LegoChem Biosciences will become a part of Orion Group’s corporate family but will keep its current management and framework.LegoChem, riding ADC sugar rush, raises $411M from sweet maker - Fierce Biotech
LegoChem Bioscience, fresh from fat | LegoChem Bioscience, fresh from fattening up on Johnson & Johnson’s cash, has found a way to feed its growing sweet tooth. Responding to the antibody-drug conjugate (ADC) sugar rush, the Korean biotech has secured 548.5 billion South Korean won ($411 million) from confectionery company Orion to support the expansion of its R&D pipeline.CORRECTING and REPLACING LegoChem Biosciences Announces License Agreement for LCB84 Trop2-Targeted ADC
DAEJEON, South Korea--(BUSINESS WIRE)-- #ADC--LegoChem Biosciences Announces License Agreement for LCB84, a Trop2 directed ADC with Janssen Biotech, Inc., a Johnson & Johnson company.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding LegoChem Biosciences
Sign Up For FreeTo access detailed company insights
LigaChem Biosciences is a biotech company dedicated to innovative drug development for over 30 years, leveraging advanced technologies and open innovation to pave new paths in global drug development. The company focuses on addressing unmet medical needs through the development of innovative therapeutics, including next-generation antibody-drug con... Read More
